Wyeth: ‘We’ve Crossed Over’

Adapting EDC To The Future

April 06, 2007

By Mark Uehling

Wyeth has been talking about the redesign of its approach and philosophy to clinical trials for years. As many readers know, the company restructured its drug discovery effort, and then tackled clinical—with some help from Accenture, which took over key…